- Exchange: NASDAQ CM
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
GenVec Inc+ Add to Watchlist
GNVC:US0.6600 USD 0.0301 4.36%
As of 20:10:00 ET on 05/17/2013.
Company Profile for GenVec Inc (GNVC)
GenVec, Inc. is a biopharmaceutical company developing novel therapeutic drugs and vaccines. The Company specializes in the treatment of cancers, including pancreatic cancer, esophageal cancer, rectal caner, and head and neck cancer. The Company is also involved in studies involving hearing loss and balance disorders. GenVec also develops vaccines for infectious diseases.
Key Executives for GenVec Inc (GNVC)
|Cynthia L CollinsPresident/CEO||Douglas J SwirskySenior VP/CFO/Treasurer/Secy|
|Bryan T ButmanSenior VP:Vector Operations||Douglas E BroughVP:Research|
|Michael C TuckerVP:Legal Affairs & Strategy|